Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: Implications in the HIT pathogenesis

Author： Ahmad Sarfraz   Untch Brian   Haas Sylvia   Hoppensteadt Debra A.   Misselwitz Frank   Messmore Harry L.   Walenga Jeanine M.   Fareed Jawed  

Publisher： Springer Publishing Company

ISSN： 0300-8177

Source： Molecular and Cellular Biochemistry, Vol.258, Iss.1, 2004-03, pp. : 163-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential Effects of Heparin and Glucose on Structural Conformation of Human alpha1 Antitrypsin: Evidence for a Heparin-Induced Cleaved Form of the Inhibitor

By Finotti P.   de Laureto P.P.  

Archives of Biochemistry and Biophysics, Vol. 347, Iss. 1, 1997-11 ,pp. : 19-29

Elsevier

Access to resources Recommend Favorite

Heparin sequencing

By Stringer Sally E.  

Glycobiology, Vol. 13, Iss. 2, 2003-02 ,pp. : 97-107

Oxford University Press

Access to resources Recommend Favorite

The Fourth Immunoglobulin-like Loop in the Extracellular Domain of FLT-1, a VEGF Receptor, Includes a Major Heparin-Binding Site

By Park M.   Lee S-T.  

Biochemical and Biophysical Research Communications, Vol. 264, Iss. 3, 1999-11 ,pp. : 730-734

Elsevier

Access to resources Recommend Favorite

Ligand Binding Properties of Binary Complexes of Heparin and Immunoglobulin-like Modules of FGF Receptor 2

By Uematsu F.   Kan M.   Wang F.   Jang J-H.   Luo Y.   McKeehan W.L.  

Biochemical and Biophysical Research Communications, Vol. 272, Iss. 3, 2000-06 ,pp. : 830-836

Elsevier

Access to resources Recommend Favorite

Chemical Microdetermination of Heparin in Plasma

By Toida T.   Huang Y.   Washio Y.   Maruyama T.   Toyoda H.   Imanari T.   Linhardt R.J.  

Analytical Biochemistry, Vol. 251, Iss. 2, 1997-09 ,pp. : 219-226

Elsevier

Access to resources Recommend Favorite